1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Interval breast cancer is associated with interferon immune response
(
- Contribution to journal › Article
- 2021
-
Mark
Association between breast cancer risk and disease aggressiveness : Characterizing underlying gene expression patterns
(
- Contribution to journal › Article
- 2019
-
Mark
Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ
(
- Contribution to journal › Article
- 2017
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
(
- Contribution to journal › Article
-
Mark
PAM50 provides prognostic information when applied to the lymph node metastases of advanced breast cancer patients
(
- Contribution to journal › Article
- 2015
-
Mark
Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications.
(
- Contribution to journal › Article
- 2014
-
Mark
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
(
- Contribution to journal › Article
- 2013
-
Mark
Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling
(
- Contribution to journal › Article
- 2012
-
Mark
Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information
(
- Contribution to journal › Article
- 2011
-
Mark
Cyclin D1, Id1 and EMT in breast cancer
(
- Contribution to journal › Article